NEWLINK GENETICS CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Vaccine Treatment for Surgically Resected Pancreatic Cancer

Phase 1
Completed
Conditions
Pancreatic Cancer
First Posted Date
2005-11-21
Last Posted Date
2020-05-28
Lead Sponsor
NewLink Genetics Corporation
Target Recruit Count
7
Registration Number
NCT00255827
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Vaccine Treatment for Hormone Refractory Prostate Cancer

First Posted Date
2005-03-04
Last Posted Date
2020-05-28
Lead Sponsor
NewLink Genetics Corporation
Target Recruit Count
8
Registration Number
NCT00105053
Locations
🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

Vaccine Treatment for Advanced Breast Cancer

Phase 1
Terminated
Conditions
Breast Cancer
Interventions
Biological: HyperAcute - Breast cancer vaccine
First Posted Date
2004-08-31
Last Posted Date
2020-05-28
Lead Sponsor
NewLink Genetics Corporation
Target Recruit Count
3
Registration Number
NCT00090480
Locations
🇺🇸

Medical Oncology Hematology Associates, Des Moines, Iowa, United States

Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

First Posted Date
2003-11-20
Last Posted Date
2020-05-28
Lead Sponsor
NewLink Genetics Corporation
Target Recruit Count
54
Registration Number
NCT00073398
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy